Arcus Biosciences, Inc. — Director's Dealing 2018

Mar 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2018-03-19

Reporting Person: Hadley Harbor Master Investors (Cayman) II L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-19	Common Stock	C	1496813	—	Acquired	1496813	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-19	Series C Convertible Preferred Stock	$	C	1496813	Disposed		Common Stock (1496813)	Direct

Footnotes

F1: The Series C Convertible Preferred Stock converted into Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The Series C Convertible Preferred Stock reported in the table above reflects a 3.96-for-1 reverse stock split that was effected in connection with the Issuer's initial public offering. The shares had no expiration date.